Search research articles
Contact Us
Filters
Showing results (261-270 of 369) with videos related to
Page
of 37
Sort By:
Acta Neuropathologica Communications
|
November 21, 2024
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients
Svenja Klinsing, Julia Beck, Katharina J Weber, et al.
Journal of Neuro-Oncology
|
July 19, 2022
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Marguerite Müller, Oliver Winz, Robin Gutsche, et al.
Cancers
|
August 7, 2020
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death
Anna-Luisa Luger, Nadja I Lorenz, Hans Urban, et al.
Neurological Research and Practice
|
May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Lukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Journal of Neuro-Oncology
|
June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
Johannes Weller, Niklas Schäfer, Christina Schaub, et al.
Cells
|
April 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
Kai Zhao, Madita Braun, Leonie Meyer, et al.
Neuro-Oncology Advances
|
March 14, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by <i>O</i>-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine PET
Michel Friedrich, Jan-Michael Werner, Joachim P Steinbach, et al.
Molecular Medicine Reports
|
October 10, 2025
Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma
Pia S Zeiner, Michael Schulz, Jana Schomber, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
Martin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Scientific Reports
|
February 16, 2023
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations
Marco M E Vogel, Arthur Wagner, Jens Gempt, et al.
Page
of 37
Search research articles
Search
Showing results (261-270 of 369) with videos related to
Sort By:
Page
of 37
Acta Neuropathologica Communications
|
November 21, 2024
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients
Svenja Klinsing, Julia Beck, Katharina J Weber, et al.
Journal of Neuro-Oncology
|
July 19, 2022
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Marguerite Müller, Oliver Winz, Robin Gutsche, et al.
Cancers
|
August 7, 2020
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death
Anna-Luisa Luger, Nadja I Lorenz, Hans Urban, et al.
Neurological Research and Practice
|
May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Lukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Journal of Neuro-Oncology
|
June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
Johannes Weller, Niklas Schäfer, Christina Schaub, et al.
Cells
|
April 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
Kai Zhao, Madita Braun, Leonie Meyer, et al.
Neuro-Oncology Advances
|
March 14, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by <i>O</i>-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine PET
Michel Friedrich, Jan-Michael Werner, Joachim P Steinbach, et al.
Molecular Medicine Reports
|
October 10, 2025
Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma
Pia S Zeiner, Michael Schulz, Jana Schomber, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
Martin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Scientific Reports
|
February 16, 2023
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations
Marco M E Vogel, Arthur Wagner, Jens Gempt, et al.
Page
of 37